MktsMarkets

Clover Health Investments, Corp.
NASDAQ: CLOVKey statistics
CLOV News
Stories mentioning CLOV from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 749,189 | 487,707 | 496,650 | 477,620 | 462,331 | 336,963 | 330,986 | 356,260 |
| Cost of Goods Sold | ||||||||
| Gross Profit | 81,212 | 107,913 | ||||||
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | ||||||||
| Total Operating Expenses | 721,855 | 537,026 | 521,027 | 488,179 | 463,605 | 358,411 | 339,771 | 349,073 |
| Operating Income (Loss) | 27,334 | (49,319) | (24,377) | (10,559) | (1,274) | (21,448) | (8,785) | 7,187 |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | 27,334 | (49,320) | (24,377) | (10,578) | (1,274) | (22,092) | (9,155) | 7,408 |
| Earnings Per Share (Basic) | 0.05 | (0.10) | 0.00 | (0.05) | ||||
| Earnings Per Share (Diluted) | 0.05 | (0.10) | 0.00 | (0.05) | ||||
| Weighted Average Shares Outstanding (Basic) | 522,184 | 511,967 | 512,744 | 509,043 | 497,056 | 490,019 | 490,180 | 487,483 |
| Weighted Average Shares Outstanding (Diluted) | 532,501 | 511,967 | 512,744 | 509,043 | 497,056 | 490,019 | 490,180 | 495,180 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About CLOV
Clover Health Investments, Corp. (NASDAQ: CLOV) is a stock listed on the Nasdaq Stock Market under the ticker symbol CLOV. It last traded at $4.48 (Oct 16, 2026, 4:00 PM ET), down 4.3% on the day. That gives Clover Health Investments a market capitalisation of $2.4B.
Over the past 52 weeks CLOV has traded between $1.58 and $5.59.
Revenue for the quarter ended Mar 31, 2026 was $749.2M; net income $27.3M. Revenue was up 62.0% from $462.3M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $749.2M | $27.3M | 3.6% |
| Dec 31, 2025 | $487.7M | -$49.3M | -10.1% |
| Sep 30, 2025 | $496.7M | -$24.4M | -4.9% |
| Jun 30, 2025 | $477.6M | -$10.6M | -2.2% |
From Clover Health Investments’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…